Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer
Background: Studies in the past have identified selected immune cells that associate with different clinical outcomes in non-small cell lung cancer (NSCLC). Considering the fact that immune responses are heterogenous and that the clinical outcome could be influenced by the interplay of various immun...
Main Authors: | Jyothi Thyagabhavan Mony, Matthew J. Schuchert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02298/full |
Similar Items
-
Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
by: Chengde Wu, et al.
Published: (2021-02-01) -
CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung Cancer
by: Yichun Tang, et al.
Published: (2022-02-01) -
VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage
by: Hengzhen Li, et al.
Published: (2024-04-01) -
Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma
by: Mei-Chee Tai, et al.
Published: (2024-02-01) -
The Role of Chemokines in Cervical Cancers
by: Fabian Garrido, et al.
Published: (2021-10-01)